- Home
- AVTX vs RVPH Comparison
AVTX vs RVPH Comparison
Compare AVTX & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$15.81
HOLD
Current Price
$0.35
Company Overview
Basic Information| Metric | AVTX | RVPH |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.4M | N/A |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVTX | RVPH |
|---|---|---|
| Price | $15.81 | $0.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $40.57 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 2.4M | 1.5M |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $3.93 | $0.17 |
| 52 Week High | $24.27 | $3.11 |
Technical Indicators
Market Signals| Indicator | AVTX | RVPH |
|---|---|---|
| Relative Strength Index (RSI) | 45.54 | 24.73 |
| Support Level | $15.33 | $0.22 |
| Resistance Level | $16.02 | $0.66 |
| Average True Range (ATR) | 1.26 | 0.07 |
| MACD | -0.37 | -0.03 |
| Stochastic Oscillator | 7.70 | 13.17 |
Price Performance
Historical Comparison AVTX
RVPH
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About RVPH Reviva Pharmaceuticals Holdings Inc.
REVIVA PHARMA HLDGS INC